Management of the oral and maxillofacial surgery patient on anabolic steroids.
Recent Food and Drug Administration estimates indicate that the anabolic steroid market has reached the $100 million level. Although the news media report steroid-related deaths, there is little in the medical literature communicating the clinical implications concerning these drugs. Electrolyte disturbances, coagulopathies, hypertension, and dysrhythmias are a few of the potential side effects. The pharmacology and pathophysiology of anabolic steroids are presented with a discussion of the anesthetic and surgical concerns for the patient undergoing oral and maxillofacial surgery.
Smith
B K
BK
Division of Oral and Maxillofacial Surgery, Cleveland Metropolitan General Hospital, OH 44109.
Haug
R H
RH
Shepard
L
L
Indresano
A T
AT
D045930:Anabolic Agents / Q000494:pharmacology; D000758:Anesthesia; D005145:Face / Q000601:surgery*; D006801:Humans; D056948:Orthognathic Surgical Procedures
D045930:Anabolic Agents